Search - tctmd.com

Displaying 341 - 360 of 540

Sort: Relevancy | Date

News Features

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

L.A. McKeown

April 18, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Industry News

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

April 07, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

Presentation ACC 2016

Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis

Presenter: Craig R. Smith

April 03, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

March 01, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

L.A. McKeown

February 07, 2016

News Industry News

LivaNova PLC Announces FDA Approval of Stented Heart Valve CROWN PRT™ for Aortic Valve Disease

January 31, 2016

News Daily News

分析显示中老年患者从机械主动脉瓣膜改用生物瓣膜可获改善

Caitlin E. Cox

January 20, 2016

News Daily News

Un Análisis Avala el Paso de Válvulas Aórticas Mecánicas a Bioprotésicas en Pacientes de Mediana Edad

Caitlin E. Cox

January 20, 2016

News Daily News

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

Caitlin E. Cox

January 20, 2016

Advertisement

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

LivaNova PLC Announces FDA Approval of Stented Heart Valve CROWN PRT™ for Aortic Valve Disease

分析显示中老年患者从机械主动脉瓣膜改用生物瓣膜可获改善

Un Análisis Avala el Paso de Válvulas Aórticas Mecánicas a Bioprotésicas en Pacientes de Mediana Edad

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content